Sofinnova Ventures »

Kyverna Therapeutics shares owned by Sofinnova Ventures

Quarter-by-quarter ownership of Kyverna Therapeutics shares owned by Sofinnova Ventures from 13F filings

Historical chart of Sofinnova Ventures investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Sofinnova Ventures

Quarter filed Position value Share count Share price at filing
2024-03-31 $248k 10k 24.84

More positions owned by Sofinnova Ventures

Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Aerovate Therapeutics (AVTE)
Merck & Co (MRK)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Novo-Nordisk A S Adr (NVO)
Incyte Corporation (INCY)
Argenx SE Sponsored Adr (ARGX)
Intuitive Surgical (ISRG)
Dyne Therapeutics (DYN)
Inhibrx (INBX)
Elanco Animal Health (ELAN)
IDEXX Laboratories (IDXX)
AstraZeneca Sponsored Adr (AZN)

View all positions for Sofinnova Ventures

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Northpond Ventures
Bain Capital Life Sciences Investors
Deerfield Management Company
Jennison Associates
T. Rowe Price Associates
Insight Holdings
Commodore Capital
Jpmorgan Chase & Co
BlackRock
Millennium Management
Henderson Group
Adage Capital Partners GP
Citadel Advisors
Logos Global Management

View all funds holding Kyverna Therapeutics